| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |